These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

278 related articles for article (PubMed ID: 32588289)

  • 1. Validation of the adjusted global antiphospholipid syndrome score in a single centre cohort of APS patients from Turkey.
    Uludağ Ö; Bektaş M; Çene E; Sezer M; Şahinkaya Y; Gül A; Inanç M; Öcal L; Artim-Esen B
    J Thromb Thrombolysis; 2021 Feb; 51(2):466-474. PubMed ID: 32588289
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Validation of the adjusted global antiphospholipid syndrome score in systemic lupus erythematosus patients in Argentina.
    Garcia L; Velloso MS; Martire MV; Savy F; Arizpe F; Garcia N; Testi A; Pena C; Costi AC; Isnardi C; Capelusnik D; Mazza S; Curi YS; Collado V; Rodriguez MF; Scarafia S; Pisoni C; de la Torre M; Seewald A; Riva ME; Garcia M
    Lupus; 2020 Dec; 29(14):1866-1872. PubMed ID: 33028177
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Thrombotic risk assessment in antiphospholipid syndrome: do noncriteria antibodies contribute?
    Uludağ Ö; Çinar S; McDonnell T; Çene E; Yalçinkaya Y; Gül A; Inanç M; Artim Esen B
    Turk J Med Sci; 2023; 53(5):1067-1074. PubMed ID: 38813003
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Thrombotic risk assessment in patients with systemic lupus erythematosus: Validation of the adjusted-Global Antiphospholipid Syndrome Score (aGAPSS) in Thai patients.
    Chanloung W; Kasitanon N; Wichainun R; Louthrenoo W
    Int J Rheum Dis; 2021 Dec; 24(12):1510-1519. PubMed ID: 34716670
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The adjusted global antiphospholipid syndrome score (aGAPSS) and the risk of recurrent thrombosis: Results from the APS ACTION cohort.
    Radin M; Sciascia S; Erkan D; Pengo V; Tektonidou MG; Ugarte A; Meroni P; Ji L; Belmont HM; Cohen H; Ramires de Jesús G; Branch DW; Fortin PR; Andreoli L; Petri M; Rodriguez E; Rodriguez-Pinto I; Knight JS; Atsumi T; Willis R; Gonzalez E; Lopez-Pedrera R; Rossi Gandara AP; Borges Gualhardo Vendramini M; Banzato A; Sevim E; Barbhaiya M; Efthymiou M; Mackie I; Bertolaccini ML; Andrade D;
    Semin Arthritis Rheum; 2019 Dec; 49(3):464-468. PubMed ID: 31153708
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Factors associated with first thrombosis in patients presenting with obstetric antiphospholipid syndrome (APS) in the APS Alliance for Clinical Trials and International Networking Clinical Database and Repository: a retrospective study.
    de Jesús GR; Sciascia S; Andrade D; Barbhaiya M; Tektonidou M; Banzato A; Pengo V; Ji L; Meroni PL; Ugarte A; Cohen H; Branch DW; Andreoli L; Belmont HM; Fortin PR; Petri M; Rodriguez E; Cervera R; Knight JS; Atsumi T; Willis R; Nascimento IS; Rosa R; Erkan D; Levy RA;
    BJOG; 2019 Apr; 126(5):656-661. PubMed ID: 30222236
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Assessing the cardiovascular risk in patients with systemic lupus erythematosus: QRISK and GAPSS scores head-to-head.
    Barinotti A; Radin M; Cecchi I; Foddai SG; Arbrile M; Rubini E; Menegatti E; Roccatello D; Sciascia S
    Int J Cardiol; 2022 Sep; 363():185-189. PubMed ID: 35714714
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Extra-criteria manifestations of antiphospholipid syndrome: Risk assessment and management.
    Radin M; Ugolini-Lopes MR; Sciascia S; Andrade D
    Semin Arthritis Rheum; 2018 Aug; 48(1):117-120. PubMed ID: 29395258
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Does Adjusted Global Antiphospholipid Syndrome Score (aGAPSS) Predict the Obstetric Outcome in Antiphospholipid Antibody Carriers? A Single-Center Study.
    Del Barrio-Longarela S; Martínez-Taboada VM; Blanco-Olavarri P; Merino A; Riancho-Zarrabeitia L; Comins-Boo A; López-Hoyos M; Hernández JL
    Clin Rev Allergy Immunol; 2022 Oct; 63(2):297-310. PubMed ID: 34910282
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Adjusted Global Antiphospholipid Syndrome Score (aGAPSS) and PLT, APTT: Predictive Value of Thrombotic Risk Assessment in SLE Patients.
    Yu P; Wang H; Li Y; Yang Y; Guo J
    Clin Lab; 2024 Jan; 70(1):. PubMed ID: 38213198
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Independent validation of the adjusted GAPSS: Role of thrombotic risk assessment in the real-life setting.
    Fernandez Mosteirin N; Saez Comet L; Salvador Osuna C; Calvo Villas JM; Velilla Marco J
    Lupus; 2017 Oct; 26(12):1328-1332. PubMed ID: 28387637
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparison of clinical and serological features in thrombotic antiphospholipid syndrome patients, with and without associated systemic lupus erythematosus, followed for up to 42 years: A single centre retrospective study.
    Mittal P; Pacheco M; Trives-Folguera L; Rua J; Tohidi-Esfahani I; Cohen H; Efthymiou M; Isenberg D
    Lupus; 2024 Sep; 33(10):1082-1088. PubMed ID: 39092568
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The adjusted Global AntiphosPholipid Syndrome Score (aGAPSS) for risk stratification in young APS patients with acute myocardial infarction.
    Radin M; Schreiber K; Costanzo P; Cecchi I; Roccatello D; Baldovino S; Bazzan M; Cuadrado MJ; Sciascia S
    Int J Cardiol; 2017 Aug; 240():72-77. PubMed ID: 28385357
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Antiphospholipid syndrome nephropathy in patients with systemic lupus erythematosus and antiphospholipid antibodies: prevalence, clinical associations, and long-term outcome.
    Tektonidou MG; Sotsiou F; Nakopoulou L; Vlachoyiannopoulos PG; Moutsopoulos HM
    Arthritis Rheum; 2004 Aug; 50(8):2569-79. PubMed ID: 15334471
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Validation of three prediction models for thrombosis recurrence in antiphospholipid syndrome patients based on a prospective cohort.
    Zhao Y; Huang C; Qi W; Zhou Y; Zhao J; Wang Q; Tian X; Li M; Zhao Y; Zeng X
    RMD Open; 2023 Jul; 9(3):. PubMed ID: 37507205
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Antiphospholipid antibodies and non-thrombotic manifestations of systemic lupus erythematosus.
    İlgen U; Yayla ME; Ateş A; Okatan İE; Yurteri EU; Torgutalp M; Keleşoğlu ABD; Turgay TM; Kınıklı G
    Lupus; 2018 Apr; 27(4):665-669. PubMed ID: 29050535
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Adjusted global antiphospholipid syndrome score (aGAPSS) is useful to predict relapses in patients with retinal vein occlusion.
    Hernández JL; Napal JJ; Icardo M; Bores PG; Pérez-Montes R; Cerveró A; Salmón Z; Olmos JM; Martínez-Taboada VM
    Thromb Res; 2023 Jan; 221():113-119. PubMed ID: 36525919
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Global Antiphospholipid Syndrome Score (GAPSS) in Patients with Systemic Lupus Erythematosus.
    Cheldieva FA; Reshetnyak TM; Shumilova AA; Nurbaeva KS; Cherkasova MV; Lila AM; Nasonov EL
    Dokl Biochem Biophys; 2023 Aug; 511(1):227-234. PubMed ID: 37833610
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Ophthalmologic manifestations in primary antiphospholipid syndrome patients: A cross-sectional analysis of a primary antiphospholipid syndrome cohort (APS-Rio) and systematic review of the literature.
    Franco AMM; Medina FMC; Balbi GGM; Levy RA; Signorelli F
    Lupus; 2020 Oct; 29(12):1528-1543. PubMed ID: 32814509
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinical utility of the global anti-phospholipid syndrome score for risk stratification: a pooled analysis.
    Sciascia S; Radin M; Sanna G; Cecchi I; Roccatello D; Bertolaccini ML
    Rheumatology (Oxford); 2018 Apr; 57(4):661-665. PubMed ID: 29342292
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.